Loxo Oncol Eli Lilly Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LOXO ONCOL ELI LILLY, and what generic alternatives to LOXO ONCOL ELI LILLY drugs are available?
LOXO ONCOL ELI LILLY has one approved drug.
There are five US patents protecting LOXO ONCOL ELI LILLY drugs.
There are one hundred and twenty-one patent family members on LOXO ONCOL ELI LILLY drugs in forty-one countries.
Summary for Loxo Oncol Eli Lilly
| International Patents: | 121 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Loxo Oncol Eli Lilly
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-001 | May 8, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-002 | May 8, 2020 | RX | Yes | Yes | 10,112,942 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-002 | May 8, 2020 | RX | Yes | Yes | 10,137,124 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Loxo Oncol Eli Lilly Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I752098 | ⤷ Try a Trial |
| New Zealand | 752793 | ⤷ Try a Trial |
| Canada | 3079012 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
